Tenofovir Disoproxil Fumarate Reduces the Severity of COVID-19 in Patients with Chronic Hepatitis B

BACKGROUND AND AIMS: HIV-positive patients on tenofovir hydroxyl fumarate (TDF)/emtricitabine have a lower risk of COVID-19 and hospitalization than those given other treatments. Our aim was to analyze the severity of COVID-19 in patients with chronic hepatitis B (CHB) on TDF or entecavir (ETV). MET...

Descripción completa

Detalles Bibliográficos
Autores principales: Mateos-Muñoz, Beatriz, Buti, María, Vázquez, Inmaculada Fernández, Conde, Marta Hernández, Bernal-Monterde, Vanesa, Díaz-Fontenla, Fernando, Morillas, Rosa María, García-Buey, Luisa, Badía, Ester, Miquel, Mireia, Amador-Navarrete, Alberto, Rodríguez-Tajes, Sergio, Ramos-Merino, Lucía, Madejón, Antonio, García-Retortillo, Montserrat, Arenas, Juan Ignacio, Cabezas, Joaquín, Santiago, Jesús Manuel González, Fernández-Rodríguez, Conrado, Cordero, Patricia, Diago, Moisés, Mancebo, Antonio, Pardo, Alberto, Rodríguez, Manuel, Hoyas, Elena, Moreno, Jose Javier, Turnes, Juan, Simón, Miguel Ángel, Marcos-Fosch, Cristina, Calleja, Jose Luis, Bañares, Rafael, Lens, Sabela, Garcia-Samaniego, Javier, Crespo, Javier, Romero-Gomez, Manuel, Gea, Francisco, de Santiago, Enrique Rodríguez, Moreno, Santiago, Albillos, Agustin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897881/
https://www.ncbi.nlm.nih.gov/pubmed/36737575
http://dx.doi.org/10.1007/s10620-022-07817-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9897881/
https://www.ncbi.nlm.nih.gov/pubmed/36737575
http://dx.doi.org/10.1007/s10620-022-07817-w

Ejemplares similares